These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2939941)

  • 1. The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytostatic drugs by the use of a capillary dialyzer.
    Schwendener RA
    Cancer Drug Deliv; 1986; 3(2):123-9. PubMed ID: 2939941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liposomes as carriers of lipophilic cytosine arabinoside and fluorodeoxyuridine derivatives. Their cytostatic effect and possibilities of tumor cell specific therapy].
    Schwendener RA; Schott H; Hartmann HR; Supersaxo A; Rubas W; Hengartner H
    Onkologie; 1987 Aug; 10(4):232-9. PubMed ID: 2959889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
    Rubas W; Supersaxo A; Weder HG; Hartmann HR; Hengartner H; Schott H; Schwendener R
    Int J Cancer; 1986 Jan; 37(1):149-54. PubMed ID: 3941019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomes.
    Supersaxo A; Rubas W; Hartmann HR; Schott H; Hengartner H; Schwendener RA
    J Microencapsul; 1988; 5(1):1-11. PubMed ID: 2974073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.
    van Borssum Waalkes M; van Galen M; Morselt H; Sternberg B; Scherphof GL
    Biochim Biophys Acta; 1993 May; 1148(1):161-72. PubMed ID: 8499464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine.
    Schwendener RA; Schott H
    Int J Cancer; 1992 May; 51(3):466-9. PubMed ID: 1592536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
    Schwendener R; Schott H
    Methods Enzymol; 2005; 391():58-70. PubMed ID: 15721374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome Formulations of Hydrophobic Drugs.
    Schwendener RA; Schott H
    Methods Mol Biol; 2017; 1522():73-82. PubMed ID: 27837531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatography of functionalized liposomes and their components.
    Schott H; Leitner B; Schwendener RA; Hengartner H
    J Chromatogr; 1988 May; 441(1):115-24. PubMed ID: 3403675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Small Unilamellar Vesicle Liposomes Using Detergent Dialysis Method.
    Zhong Q; Zhang H
    Methods Mol Biol; 2023; 2622():49-56. PubMed ID: 36781748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
    Rahman YE; Patel KR; Cerny EA; Maccoss M
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1105-12. PubMed ID: 6540691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome formulations of hydrophobic drugs.
    Schwendener RA; Schott H
    Methods Mol Biol; 2010; 605():129-38. PubMed ID: 20072877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine--novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results.
    Schwendener RA; Supersaxo A; Rubas W; Weder HG; Hartmann HR; Schott H; Ziegler A; Hengartner H
    Biochem Biophys Res Commun; 1985 Jan; 126(2):660-6. PubMed ID: 3156589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics.
    Jiskoot W; Teerlink T; Beuvery EC; Crommelin DJ
    Pharm Weekbl Sci; 1986 Oct; 8(5):259-65. PubMed ID: 3786108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a liposome dialyzer for the preparation of high-value, small-volume liposome formulations.
    Adamala K; Engelhart AE; Kamat NP; Jin L; Szostak JW
    Nat Protoc; 2015 Jun; 10(6):927-38. PubMed ID: 26020615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of hemoglobin-containing liposomes using octyl glucoside and octyltetraoxyethylene.
    Jopski B; Pirkl V; Jaroni HW; Schubert R; Schmidt KH
    Biochim Biophys Acta; 1989 Jan; 978(1):79-84. PubMed ID: 2914131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
    Mori A; Kennel SJ; Huang L
    Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
    Jaafar-Maalej C; Diab R; Andrieu V; Elaissari A; Fessi H
    J Liposome Res; 2010 Sep; 20(3):228-43. PubMed ID: 19899957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
    Koning GA; Morselt HW; Velinova MJ; Donga J; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
    Biochim Biophys Acta; 1999 Aug; 1420(1-2):153-67. PubMed ID: 10446299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles.
    Zumbuehl O; Weder HG
    Biochim Biophys Acta; 1981 Jan; 640(1):252-62. PubMed ID: 7194112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.